Skip to content
10-Q

Quarterly Report

APPLIED GENETIC TECHNOLOGIES CORP

0001193125-22-039861

← back to feed
Filed
Feb 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Feb 9, 2022 42.92M sh
Shares Diluted Q2 2022 · Dec 31, 2021 42.89M sh
Shares Diluted Q2 2022 · Dec 31, 2021 42.86M sh
Shares Diluted Q2 2022 · Dec 31, 2020 25.88M sh
Shares Diluted Q2 2022 · Dec 31, 2020 25.85M sh
Capex Q2 2022 · Dec 31, 2021 $821K
Capex Q2 2022 · Dec 31, 2020 $768K
Operating Cash Flow Q2 2022 · Dec 31, 2021 −$33.49M
Operating Cash Flow Q2 2022 · Dec 31, 2020 −$26.31M
Long Term Debt Q2 2022 · Dec 31, 2021 $13.54M
Long Term Debt Q2 2022 · Jun 30, 2021 $17.73M
Short Term Debt Q2 2022 · Dec 31, 2021 $6.71M
Short Term Debt Q2 2022 · Jun 30, 2021 $2.18M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $72.77M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $105.05M
Stockholders Equity Q2 2022 · Dec 31, 2021 $51.49M
Stockholders Equity Q2 2022 · Sep 30, 2021 $69.53M
Stockholders Equity Q2 2022 · Jun 30, 2021 $85.81M
Stockholders Equity Q2 2022 · Dec 31, 2020 $41.52M
Stockholders Equity Q2 2022 · Sep 30, 2020 $56.2M
Stockholders Equity Q2 2022 · Jun 30, 2020 $71.02M
Current Liabilities Q2 2022 · Dec 31, 2021 $24.11M
Current Liabilities Q2 2022 · Jun 30, 2021 $19.71M
Total Liabilities Q2 2022 · Dec 31, 2021 $40.88M
Total Liabilities Q2 2022 · Jun 30, 2021 $41.16M
Current Assets Q2 2022 · Dec 31, 2021 $75.37M
Current Assets Q2 2022 · Jun 30, 2021 $109.71M
Total Assets Q2 2022 · Dec 31, 2021 $92.37M
Total Assets Q2 2022 · Jun 30, 2021 $126.97M
Eps Diluted Q2 2022 · Dec 31, 2021 −$0.45
Eps Diluted Q2 2022 · Dec 31, 2021 −$0.85
Eps Diluted Q2 2022 · Dec 31, 2020 −$0.60
Eps Diluted Q2 2022 · Dec 31, 2020 −$1.19
Eps Basic Q2 2022 · Dec 31, 2021 −$0.45
Eps Basic Q2 2022 · Dec 31, 2021 −$0.85
Eps Basic Q2 2022 · Dec 31, 2020 −$0.60
Eps Basic Q2 2022 · Dec 31, 2020 −$1.19
Sga Expense Q2 2022 · Dec 31, 2021 $3.99M
Sga Expense Q2 2022 · Dec 31, 2021 $8.09M
Sga Expense Q2 2022 · Dec 31, 2020 $3.3M
Sga Expense Q2 2022 · Dec 31, 2020 $6.74M
Rd Expense Q2 2022 · Dec 31, 2021 $14.45M
Rd Expense Q2 2022 · Dec 31, 2021 $26.78M
Rd Expense Q2 2022 · Dec 31, 2020 $11.81M
Rd Expense Q2 2022 · Dec 31, 2020 $23.44M
Net Income Q2 2022 · Dec 31, 2021 −$19.14M
Net Income Q2 2022 · Dec 31, 2021 −$36.26M
Net Income Q2 2022 · Sep 30, 2021 −$17.12M
Net Income Q2 2022 · Dec 31, 2020 −$15.46M
Net Income Q2 2022 · Dec 31, 2020 −$30.84M
Net Income Q2 2022 · Sep 30, 2020 −$15.38M
Operating Income Q2 2022 · Dec 31, 2021 −$18.44M
Operating Income Q2 2022 · Dec 31, 2021 −$34.87M
Operating Income Q2 2022 · Dec 31, 2020 −$15.12M
Operating Income Q2 2022 · Dec 31, 2020 −$30.18M
Revenue Q2 2022 · Dec 31, 2021 $0
Revenue Q2 2022 · Dec 31, 2021 $0
Revenue Q2 2022 · Dec 31, 2020 $0
Revenue Q2 2022 · Dec 31, 2020 $0
Short Term Investments Q2 2022 · Jun 30, 2021 $2M